- 0 replies
- 165 views
- 0 followings
We are Looking for Hypertrophic Cardiomyopathy (HCM) Patient Representatives
The AHA is starting a three-year HCM initiative sponsored by Myokardia, a pharmaceutical company focused on pioneering precision cardiac medicine to develop targeted therapies for the treatment of HCM and other cardiovascular diseases.
The HCM initiative will focus on driving awareness and effective management strategies among diagnosed HCM patients and at-risk individuals, while driving HCM education focused on promoting better detection and management of HCM by health care providers.
The only prerequisite for this representative role is a medically verified diagnosis of HCM. No professional medical expertise or knowledge is expected or required.
If you are interested in participating, please email us at SupportNetwork@heart.org